<DOC>
	<DOCNO>NCT00151892</DOCNO>
	<brief_summary>Ulcerative colitis disease large bowel ( colon ) rectum line bowel becomes red swollen . Over time , patient disease may experience acute episode diarrhea , rectal bleed abdominal pain follow period time without disease symptom . 5-ASA drug standard treatment ulcerative colitis . Mesalazine experimental drug design gradually release 5-ASA area large bowel associate ulcerative colitis . This study test safety efficacy mesalazine keep ulcerative colitis remission .</brief_summary>
	<brief_title>Efficacy Safety SPD476 Maintaining Remission Patients With Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Mesalamine</mesh_term>
	<criteria>previous diagnosis ulcerative colitis confirm histology consider remission = &gt; 30 day female subject must postmenopausal , surgically biologically sterile , negative urine pregnancy test screen adequate contraception proctitis previous resective colonic surgery Crohn 's disease hypersensitivity salicylates moderate/severe renal impairment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>